Actively Recruiting
Integration of a Behavioral Health Collaborative Care Model Into an ICU Recovery Clinic
Led by Medical University of South Carolina · Updated on 2026-03-12
150
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Medical University of South Carolina
Lead Sponsor
H
Health Resources and Services Administration (HRSA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Survivors of critical illness often face mental health challenges such as anxiety, depression, and post-traumatic stress disorder (PTSD). Researchers are evaluating a behavioral health Collaborative Care Model (BH CoCM) compared to usual care for patients recovering in an ICU Recovery Clinic. This randomized controlled trial aims to study these mental health outcomes over six months at a single site. Participants are randomly assigned to either an intervention group receiving BH CoCM or an attention control group receiving usual care. The intervention group uses the NeuroFlow digital platform for six months, which supports behavioral health care. They receive behavioral health coaching and psychiatric support as needed, while both groups undergo assessments for anxiety, depression, and post-traumatic stress symptoms. During the study, participants will complete regular assessments to monitor mental health symptoms. Investigators will track changes in depression, anxiety, and post-traumatic stress over six months, as well as adherence to the intervention and usage of NeuroFlow content. Surveys will also be conducted to gather participant feedback on the intervention and explore potential improvements. The total participation duration is six months from enrollment.
CONDITIONS
Brief Title
Behavioral Health Collaborative Care Model in an ICU Recovery Clinic
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Attendance at the MUSC ICU Recovery Clinic within 180 days of discharge from the hospital
You will not qualify if you...
- ICU admission due to a primary addiction diagnosis such as alcohol withdrawal or delirium tremens requiring ICU care
- Serious mental illness such as schizophrenia, psychotic disorder, or acute mania
- Late stage dementia or cognitive impairment
- Limited English or Spanish proficiency
- Lack of regular access to a computer, tablet, or mobile device with internet access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants in the intervention group utilize the NeuroFlow platform and receive behavioral health coaching and psychiatric support for 6 months. Participants in the control group undergo regular assessments without the intervention.
Regular assessments during the 6 months
Trial Site Locations
Total: 1 location
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29407
Actively Recruiting
Research Team
R
Rita Bakhru, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here